A senior official said on Monday that Thailand will stop using the COVID-19 vaccine developed by China's Sinovac when its current stock finishes, as reported by Fidelity.
Thailand has used over 31.5 million Sinovac doses since February. In July, Thailand started inoculating people with Sinovac as a first dose followed by the Oxford-AstraZeneca vaccine.
The country was the first to combine Chinese and Western shots, a strategy its health officials said has proved effective.
"We expect to have distributed all Sinovac doses this week," said health official Opas Karnkawinpong, adding the programme will switch to combining the AstraZeneca vaccine with the Pfizer-BioNTech vaccine.
Next year, Thailand plans to buy 120 million COVID-19 vaccine doses in total and has already booked 60 million doses of AstraZeneca, which it manufactures locally.